Oncolytic virus based cell therapy (Hospital Infantil Universitario Nino Jesus/Orgenesis)

N/A

Report date: 2024/06/03 12:01:09

Base Information

Drug NameOncolytic virus based cell therapy (Hospital Infantil Universitario Nino Jesus/Orgenesis)
Drug Alias NameIcovir-5Icovir-5-infected autologous mesenchymal stem cellsAloCelyvirCelyvirOncolytic adenovirus ICOVIR5-infected autologous mesenchymal stem cells +[6] 
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsUveal melanomaSolid tumoursNeoplasm Metastasis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHospital Infantil Universitario Nino Jesus
China Registration ClassN/A

Develop Information

Active CompaniesHospital Infantil Universitario Nino JesusInstituto De Salud Carlos Iii
Inactive CompaniesN/A
Active IndicationsUveal melanomaMedulloblastomaDiffuse Intrinsic Pontine Glioma
Inactive IndicationsSolid tumoursNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A